NCT04217733View on ClinicalTrials.gov

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 1, 2030

Study Completion Date

December 30, 2030

Conditions
IBS - Irritable Bowel Syndrome
Interventions
DRUG

pentoxyifylline

Pentoxyifylline two times daily for 3 months

DRUG

Mebeverine

Mebeverine 3 times for 3 months

DRUG

ethosuximide

ethosuximide 3 times for 3 months

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors
lead

Tanta University

OTHER